Finch Therapeutics Group (FNCH) Stock Chart & Stock Price History → Fidelity, Bezos, Goldman Bet Big on Tiny Biotech (From Behind the Markets) (Ad) Free FNCH Stock Alerts $2.12 -0.06 (-2.75%) (As of 05/8/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Finch Therapeutics Group Stock Price Performance5 Day Performance-7.83%1 Month Performance-4.93%3 Month Performance-17.51%6 Month Performance-44.21%Year-To-Date Performance-41.27%1 Year Performance-82.11% Receive FNCH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Finch Therapeutics Group and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. FNCH Stock Chart for Wednesday, May, 8, 2024 FNCH Chart by TradingView Finch Therapeutics Group Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2024$2.24$2.18-2.68%$2.26$2.1321,386 shs$3.51 million05/06/2024$2.30$2.24-2.61%$2.65$2.13250,489 shs$3.60 million05/03/2024$2.49$2.30-7.63%$2.65$2.2453,241 shs$3.70 million05/02/2024$2.31$2.49+7.79%$2.60$2.3159,043 shs$4.01 million05/01/2024$2.34$2.31-1.28%$2.34$2.281,827 shs$3.71 million04/30/2024$2.30$2.34+1.74%$2.38$2.1615,680 shs$3.77 million Get the Latest News and Ratings for FNCH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Finch Therapeutics Group and its competitors with MarketBeat's FREE daily newsletter. 04/29/2024$2.32$2.30-0.86%$2.38$2.1639,285 shs$3.70 million04/26/2024$2.24$2.32+3.57%$2.43$2.1037,434 shs$3.74 million04/25/2024$2.30$2.24-2.61%$2.31$2.1041,613 shs$3.61 million04/24/2024$2.78$2.30-17.27%$2.63$2.25117,052 shs$3.70 million04/23/2024$2.31$2.78+20.35%$3.08$2.39686,520 shs$4.48 million04/22/2024$2.24$2.31+3.12%$2.40$2.1022,468 shs$3.71 million04/19/2024$2.35$2.24-4.68%$2.29$2.1629,864 shs$3.61 million04/18/2024$2.52$2.35-6.75%$2.42$2.0926,217 shs$3.78 million04/17/2024$3.10$2.52-18.71%$3.13$2.35127,984 shs$4.05 million04/16/2024$2.25$3.10+38.08%$3.37$2.11703,480 shs$4.99 million04/15/2024$2.03$2.25+10.59%$2.34$1.9719,660 shs$3.61 million04/12/2024$2.35$2.08-11.49%$2.35$1.8733,143 shs$3.35 million04/11/2024$2.45$2.35-4.08%$2.39$2.2320,765 shs$3.78 million04/10/2024$2.45$2.45$2.49$2.451,686 shs$3.95 million04/09/2024$2.23$2.45+9.87%$2.53$2.1423,969 shs$3.95 million04/08/2024$2.20$2.23+1.32%$2.32$2.1421,756 shs$3.59 million04/05/2024$2.29$2.24-2.18%$2.40$2.1616,459 shs$3.61 million04/04/2024$2.36$2.29-2.97%$2.53$2.1520,204 shs$3.69 million04/03/2024$2.51$2.36-5.98%$2.49$2.3517,917 shs$3.80 million04/02/2024$2.56$2.51-1.95%$2.54$2.326,894 shs$4.04 million04/01/2024$2.60$2.56-1.54%$2.60$2.503,998 shs$4.12 million03/29/2024$2.60$2.60+0.00%$2.86$2.4815,852 shs$4.19 million03/28/2024$2.84$2.60-8.45%$2.86$2.4815,848 shs$4.19 million03/27/2024$2.61$2.84+8.81%$3.16$2.643,401 shs$4.57 million03/26/2024$2.78$2.61-6.12%$2.66$2.612,421 shs$4.20 million03/25/2024$2.57$2.78+8.17%$2.81$2.685,236 shs$4.48 million03/22/2024$2.61$2.62+0.38%$2.68$2.555,402 shs$4.22 million03/21/2024$2.74$2.61-4.74%$2.79$2.618,605 shs$4.20 million03/20/2024$2.79$2.74-1.79%$2.79$2.675,208 shs$4.41 million03/19/2024$2.70$2.79+3.33%$2.86$2.512,275 shs$4.49 million03/18/2024$2.56$2.70+5.68%$2.80$2.6115,212 shs$4.35 million03/15/2024$2.47$2.56+3.44%$2.56$2.454,092 shs$4.11 million03/14/2024$2.56$2.47-3.52%$2.64$2.4611,987 shs$3.97 million03/13/2024$2.67$2.56-4.12%$2.81$2.4226,335 shs$4.11 millionFidelity, Bezos, Goldman Bet Big on Tiny Biotech (Ad)Are you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.Don't miss out on the "next Ozempic" >>>03/12/2024$3.42$2.67-21.93%$3.10$2.6274,308 shs$4.30 million03/11/2024$2.50$3.42+36.80%$4.46$2.51386,508 shs$5.51 million03/08/2024$2.42$2.50+3.31%$2.51$2.371,153 shs$4.03 million03/07/2024$2.54$2.42-4.72%$2.51$2.375,574 shs$3.90 million03/06/2024$2.50$2.54+1.60%$2.54$2.403,002 shs$4.09 million03/05/2024$2.64$2.50-5.30%$2.66$2.354,794 shs$4.03 million03/04/2024$2.72$2.64-2.94%$2.84$2.6312,386 shs$4.24 million03/01/2024$2.60$2.73+5.00%$2.89$2.6219,939 shs$4.40 million02/29/2024$2.61$2.60-0.38%$2.70$2.482,596 shs$4.19 million02/28/2024$2.54$2.61+2.90%$2.72$2.386,023 shs$4.20 million02/27/2024$2.57$2.54-1.30%$2.68$2.385,864 shs$4.08 million02/26/2024$2.42$2.57+6.20%$2.70$2.4316,372 shs$4.14 million02/23/2024$2.31$2.41+4.33%$2.47$2.267,345 shs$3.88 million02/22/2024$2.48$2.31-6.85%$2.54$2.2515,681 shs$3.72 million02/21/2024$2.42$2.48+2.48%$2.50$2.421,191 shs$3.99 million02/20/2024$2.50$2.42-3.20%$2.67$2.3820,860 shs$3.90 million02/19/2024$2.50$2.50$2.65$2.3115,500 shs$4.03 million02/16/2024$2.50$2.50$2.65$2.3114,581 shs$4.03 million02/15/2024$2.34$2.50+6.84%$2.65$2.1919,410 shs$4.02 million02/14/2024$2.54$2.34-7.69%$2.58$2.2010,734 shs$3.76 million02/13/2024$2.52$2.54+0.60%$2.67$2.3512,260 shs$4.08 million02/12/2024$2.55$2.52-1.18%$2.71$2.521,274 shs$4.06 million02/09/2024$2.57$2.55-0.78%$2.64$2.504,631 shs$4.11 million02/08/2024$2.53$2.57+1.58%$2.59$2.483,490 shs$4.14 million02/07/2024$2.79$2.53-9.32%$2.82$2.535,229 shs$4.07 million Related Companies: TCON Stock Price Chart KRBP Stock Price Chart ALBT Stock Price Chart ELOX Stock Price Chart GMDAQ Stock Price Chart GMDA Stock Price Chart PALI Stock Price Chart FRTX Stock Price Chart XXII Stock Price Chart CELZ Stock Price Chart Receive FNCH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Finch Therapeutics Group and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:FNCH) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe AI Stock that’s Disrupting Every IndustryStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Finch Therapeutics Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.